Co-Diagnostics Adds 5% In Morning Trade

On:

Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.

The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.

As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.

CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.

Source: Read Full Article

Lates News:
  1. Markets Cheer U.S. GDP Data While Waiting For Jackson Hole Cues
  2. CureVac Rallies On Positive Data From Its COVID-19, Flu Vaccine Candidates
  3. Fastenal Slips As Sales Miss Expectations
  4. $BTC: A Weaker U.S. Dollar Allows Bitcoin and Rest of the Crypto Market to Move Higher
  5. The Spot Bitcoin ETF Dream Shelved as More Regulatory Obstacles Block Approval